{"id":"https://openalex.org/W4244761909","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.7017","title":"Mitochondrial profiling as a predictive biomarker for response to cytarabine-based treatment of acute myelogenous leukemia.","display_name":"Mitochondrial profiling as a predictive biomarker for response to cytarabine-based treatment of acute myelogenous leukemia.","publication_year":2016,"publication_date":"2016-05-20","ids":{"openalex":"https://openalex.org/W4244761909","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.7017"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2016.34.15_suppl.7017","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.7017","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.7017","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048618968","display_name":"Elisha J. Dettman","orcid":"https://orcid.org/0000-0002-0059-836X","observed_orcids":["https://orcid.org/0000-0002-0059-836X"]},"institutions":[{"id":"https://openalex.org/I4210137507","display_name":"Eutropics Pharmaceuticals (United States)","ror":"https://ror.org/03kaqgs21","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137507"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E.J. Dettman","raw_affiliation_strings":["Eutropics Pharmaceuticals, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eutropics Pharmaceuticals, Cambridge, MA;","institution_ids":["https://openalex.org/I4210137507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025033934","display_name":"Camille E. Doykan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137507","display_name":"Eutropics Pharmaceuticals (United States)","ror":"https://ror.org/03kaqgs21","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137507"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Camille Doykan","raw_affiliation_strings":["Eutropics Pharmaceuticals, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eutropics Pharmaceuticals, Cambridge, MA;","institution_ids":["https://openalex.org/I4210137507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052090140","display_name":"Michael H. Cardone","orcid":"https://orcid.org/0000-0001-6484-5473","observed_orcids":["https://orcid.org/0000-0001-6484-5473","https://orcid.org/0009-0001-0356-7681"]},"institutions":[{"id":"https://openalex.org/I4210137507","display_name":"Eutropics Pharmaceuticals (United States)","ror":"https://ror.org/03kaqgs21","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137507"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael H. Cardone","raw_affiliation_strings":["Eutropics, Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eutropics, Inc., Cambridge, MA;","institution_ids":["https://openalex.org/I4210137507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046387225","display_name":"Robert Kerrin Hills","orcid":"https://orcid.org/0000-0003-0166-0062","observed_orcids":["https://orcid.org/0000-0003-0166-0062"]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Robert Hills","raw_affiliation_strings":["Cardiff University School of Medicine, Cardiff, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiff University School of Medicine, Cardiff, United Kingdom;","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Paul White","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul White","raw_affiliation_strings":["Cardiff University School of Medicine, Cardiff, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiff University School of Medicine, Cardiff, United Kingdom;","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013645809","display_name":"Alan K. Burnett","orcid":"https://orcid.org/0000-0003-1734-5817","observed_orcids":["https://orcid.org/0000-0003-1734-5817"]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alan Kenneth Burnett","raw_affiliation_strings":["Cardiff University School of Medicine, Cardiff, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiff University School of Medicine, Cardiff, United Kingdom;","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079262854","display_name":"Michael Andreeff","orcid":"https://orcid.org/0000-0002-1144-1958","observed_orcids":["https://orcid.org/0000-0002-1144-1958"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Andreeff","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"15_suppl","first_page":"7017","last_page":"7017"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.949999988079071},{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.8560000061988831},{"id":"https://openalex.org/keywords/7-3-regimen","display_name":"7+3 regimen","score":0.906000018119812},{"id":"https://openalex.org/keywords/high-dose-cytarabine","display_name":"high-dose cytarabine","score":0.777999997138977},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7990000247955322},{"id":"https://openalex.org/keywords/apoptosis-sensitivity","display_name":"apoptosis sensitivity","score":0.5889999866485596},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.9259999990463257},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bcl-2-family-proteins","display_name":"Bcl-2 family proteins","score":0.9100000262260437},{"id":"https://openalex.org/keywords/personalized-medicine","display_name":"personalized medicine","score":0.6589999794960022}],"concepts":[{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.845197319984436},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7499994039535522},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6482825875282288},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5210849046707153},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4936879575252533},{"id":"https://openalex.org/C3019719930","wikidata":"https://www.wikidata.org/wiki/Q3910099","display_name":"Predictive value","level":2,"score":0.48314327001571655},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.46616727113723755},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.44798168540000916},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.43424972891807556},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3372983932495117},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33612948656082153},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12030008435249329},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2016.34.15_suppl.7017","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.7017","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.7017","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2598749276","https://openalex.org/W7099646390","https://openalex.org/W7095645596","https://openalex.org/W2115272811","https://openalex.org/W2016398606","https://openalex.org/W2083086786","https://openalex.org/W2586386095","https://openalex.org/W7096562014","https://openalex.org/W4311916228","https://openalex.org/W2057414588"],"abstract_inverted_index":{"7017":[0],"Background:":[1],"Acute":[2],"Myelogenous":[3],"Leukemia":[4],"(AML)":[5],"remains":[6],"a":[7,24,81,139,185,234,241,290,300],"poorly":[8],"treated":[9,183,195],"disease,":[10],"which":[11],"personalized":[12],"medicine":[13],"may":[14],"improve":[15],"by":[16,106],"identifying":[17],"the":[18,32,51,63,71,93,134,161,168,219,258,295,307,322],"best":[19,33,52],"therapy":[20],"option":[21,54],"based":[22,38,188,342],"on":[23,39],"patient\u2019s":[25],"molecular":[26],"or":[27],"genetic":[28],"makeup.":[29],"To":[30],"date,":[31],"biomarkers":[34],"in":[35,68,113,131,181,264,306],"AML":[36,69,146,276],"are":[37,56,319,335],"cytogenetic":[40,259],"risk":[41,260],"category":[42,261],"and":[43,55,173,177,240,262,284,316,325],"age;":[44],"however,":[45],"these":[46],"characteristics":[47],"cannot":[48],"accurately":[49],"identify":[50,125,332],"treatment":[53,87],"prognostic":[57],"rather":[58],"than":[59],"predictive.":[60],"One":[61],"of":[62,73,95,110,115,117,128,216,238,245,275],"most":[64,148,336],"promising":[65],"predictive":[66,236,243],"tests":[67],"involves":[70,92],"measurement":[72],"apoptotic":[74],"sensitivities,":[75],"as":[76],"mitochondrial":[77],"apoptosis":[78,129],"induction":[79,116],"is":[80,212],"hallmark":[82],"for":[83,160],"response":[84,112,217,315],"to":[85,124,150,152,198,218,257,303,331,338,340],"many":[86],"modalities.":[88],"Methods:":[89],"Mitochondrial":[90],"profiling":[91],"perturbation":[94],"cells":[96],"with":[97,184,193,203,227,233,282,321],"specific":[98,126],"BH3":[99,163],"(BCL2":[100],"Homology":[101],"Domain":[102],"3)":[103],"peptides,":[104],"followed":[105],"flow":[107],"cytometric":[108],"measurements":[109],"their":[111],"terms":[114],"apoptosis.":[118],"This":[119],"method":[120],"can":[121,328],"be":[122,329],"used":[123,330],"blocks":[127],"present":[130],"leukemias":[132],"at":[133],"single":[135,249],"cell":[136],"level.":[137],"In":[138],"previous":[140],"study,":[141],"we":[142,166],"identified":[143],"that":[144,210,268,278,314,334],"those":[145],"patients":[147,182,333],"likely":[149,337],"respond":[151,339],"high":[153],"dose":[154],"ara-C":[155,187,341],"(HiDAC)":[156],"were":[157],"highly":[158],"primed":[159],"BIM":[162,171,204,222,253,269,287,323],"peptide.":[164],"Here,":[165],"examined":[167],"relationship":[169],"between":[170],"priming":[172,205,223,254,270],"complete":[174],"remission":[175],"(CR)":[176],"overall":[178],"survival":[179],"(OS)":[180],"standard":[186],"7+3":[189,199,220],"regimen.":[190,221],"Results:":[191],"As":[192],"HiDAC":[194],"patients,":[196],"CR":[197],"was":[200,224,255,279],"significantly":[201],"associated":[202,226,320],"(p":[206,230],"=":[207,231],"0.05),":[208],"showing":[209],"it":[211],"an":[213,272],"excellent":[214],"predictor":[215],"also":[225],"longer":[228],"OS":[229],"0.049),":[232],"positive":[235],"value":[237,244],"80%":[239],"negative":[242],"70%":[246],"using":[247],"this":[248,326],"biomarker":[250],"test.":[251],"Additionally,":[252],"additive":[256],"age":[263],"predicting":[265],"response,":[266],"suggesting":[267,299],"captures":[271],"additional":[273],"dimension":[274],"biology":[277],"not":[280],"measured":[281],"cytogenetics":[283],"age.":[285],"The":[286],"peptide":[288],"has":[289],"broad":[291],"binding":[292],"range":[293],"among":[294],"BCL-2":[296],"family":[297],"members":[298],"general":[301],"sensitivity":[302],"pro-apoptotic":[304],"stimuli":[305],"responsive":[308],"leukemias.":[309],"Conclusions:":[310],"These":[311],"results":[312],"demonstrate":[313],"favorable":[317],"outcomes":[318],"biomarker,":[324],"test":[327],"therapies.":[343]},"counts_by_year":[],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2022-05-12T00:00:00"}